The US President's Emergency Plan for AIDS Relief (PEPFAR), the largest global health investment ever by any country to ...

Twice-yearly injectables might soon be available to help prevent HIV infection. The injectable Sunlenca is even more ...

In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with ...

For years, Gilead Sciences was dead money for shareholders. That is starting to change, and a recent rally in the stock can ...

Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop ...